Evidence map›Paper›PMID 36106781›Full record

ReviewJournal of clinical pharmacology2022

Predicting Human Fetal Drug Exposure Through Maternal-Fetal PBPK Modeling and In Vitro or Ex Vivo Studies.

Ankit Balhara, Aditya R Kumar, Jashvant D Unadkat

Abstract readReview
In one paragraph

Review in Journal of clinical pharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Physiologically based pharmacokinetic modeling of small molecules: How much progress have we made?Drug metabolism and disposition: the biological fate of chemicals · 2025
    Review
  11. Review
  12. Review
  13. Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ankit BalharaDepartment of Pharmaceutics, University of Washington, Seattle, Washington, USA.
Aditya R KumarDepartment of Pharmaceutics, University of Washington, Seattle, Washington, USA.
Jashvant D UnadkatDepartment of Pharmaceutics, University of Washington, Seattle, Washington, USA.

Funding

Pharmacological Sciences SupplementT32GM007750 · NIGMS · UNIVERSITY OF WASHINGTON · PI ATKINS, WILLIAM M · 1985 to 2023
$12.6M
Understanding Fetal Exposure to Cannabinoids Through In Vitro and In Vivo StudiesP01DA032507 · NIDA · UNIVERSITY OF WASHINGTON · PI UNADKAT, JASHVANT D · 2013 to 2023
$12.4M
NRSA Training CoreTL1TR002318 · NCATS · UNIVERSITY OF WASHINGTON · PI Megan Moore · 2017 to 2026
$8.4M
A Systems Pharmacology approach to predict the effects of pregnancy and infectious diseases on transporter-mediated drug dispositionR01HD102786 · NICHD · UNIVERSITY OF WASHINGTON · PI LANCHOTE, VERA LUCIA, UNADKAT, JASHVANT D · 2021 to 2024
$2.1M
NCATS NIH HHS TL1 TR002318NICHD NIH HHS R01 HD102786NIDA NIH HHS P01 DA032507NIGMS NIH HHS T32 GM007750
6 · The paper itself

Abstract

Medication (drug) use in human pregnancy is prevalent. Determining fetal safety and efficacy of drugs is logistically challenging. However, predicting (not measuring) fetal drug exposure (systemic and tissue) throughout pregnancy is possible through maternal-fetal physiologically based pharmacokinetic (PBPK) modeling and simulation. Such prediction can inform fetal drug safety and efficacy. Fetal drug exposure can be quantified in 2 complementary ways. First, the ratio of the steady-state unbound plasma concentration in the fetal plasma (or area under the plasma concentration-time curve) to the corresponding maternal plasma concentration (ie, K

Indexed as

Maternal-Fetal ExchangePlacentaAnimalsComputer SimulationFemaleFetusHumansModels, BiologicalPregnancyin vitro to in vivo extrapolationmaternal-fetal PBPK modelperfused placentapredicting fetal drug exposuretransfected and placental cell linestransporters and enzymes

Identifiers

PMID36106781
PMCPMC9494623

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.